CIP
FATE icon

Chartwell Investment Partners’s Fate Therapeutics FATE Stock Holding History

Chartwell Investment Partners’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-11,708
Closed -$685K – 427
2021
Q4 		$685K Sell
11,708
-207
-2% -$11.7K 0.02% 400
2021
Q3 		$706K Hold
11,915
– – 0.02% 398
2021
Q2 		$1.03M Buy
11,915
+6,305
+112% +$508K 0.03% 372
2021
Q1 		$463K Sell
5,610
-300
-5% -$28.7K 0.01% 401
2020
Q4 		$537K Buy
+5,910
New +$367K 0.02% 399
2018
Q3 		– Sell
-77,304
Closed -$877K – 480
2018
Q2 		$877K Sell
77,304
-2,943
-4% -$32.4K 0.03% 451
2018
Q1 		$783K Buy
+80,247
New +$769K 0.03% 382

Other funds holding FATE

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return